Flunixin Meglumine Injectable Solution for Horses & Cattle, 50 mg/mL, 100 mL Vial

Flunixin Meglumine Injectable Solution is a professional-grade veterinary non-steroidal anti-inflammatory drug (NSAID) formulated for parenteral administration in horses and cattle to provide rapid, potent analgesia, anti-inflammatory action, and antipyretic therapy. Containing the active non-selective cyclooxygenase inhibitor flunixin meglumine, this therapeutic preparation effectively suppresses prostaglandin synthesis to mitigate visceral pain (such as equine colic), acute musculoskeletal inflammation, and systemic endotoxemia. Because of its rapid systemic onset and potent pharmacological profile, administration requires precise veterinary diagnosis, careful weight-based dosing, and strict adherence to clinical safety guidelines.

What Is Flunixin Meglumine Injectable Solution?

Flunixin Meglumine Injectable Solution is a specialized veterinary non-steroidal anti-inflammatory compound formulated for parenteral delivery under professional veterinary supervision.

Active Ingredients and Formulation

• Active Component: Flunixin meglumine at a concentration equivalent to 50 mg per mL of active flunixin base. It acts as a potent, non-selective inhibitor of the cyclooxygenase (COX-1 and COX-2) enzymes, rapidly reducing inflammatory cascades and pain pathways.

• Vehicle and Presentation: Supplied as a sterile, non-aqueous aqueous-miscible injectable solution packaged in a multi-dose glass or plastic vial (such as 100 mL) designed for aseptic veterinary dispensing.

What Is It Used For?

Primary Veterinary Indications

• Equine Colic Relief: Routinely prescribed by equine veterinarians as a primary emergency analgesic to control severe visceral pain and abdominal discomfort associated with equine colic.

• Musculoskeletal Pain and Lameness: Alleviates acute pain, swelling, and lameness linked to soft tissue injuries, bone disorders, myositis, and joint flare-ups in horses.

• Bovine Inflammatory and Pyrexia Support: Utilized in cattle to control acute inflammation and pyrexia associated with bovine respiratory disease (BRD), acute mastitis, and endotoxic shock.

Administration and Dosage Considerations

Route and Dosing

• Route of Administration: Administered via intravenous (I.V.) injection (preferred for rapid onset, particularly in equine colic cases) or intramuscular (I.M.) injection in horses and cattle.

• Standard Equine Dosage Reference:

  • Musculoskeletal Pain: Typically administered at 0.5 mg per lb (1.1 mg per kg) of body weight once daily as needed for up to 5 consecutive days.

  • Colic Pain: Administered at 0.5 mg per lb (1.1 mg per kg) intravenously, which may be repeated once or twice if colic symptoms recur.

• Standard Bovine Dosage Reference: Typically administered at 1.1 to 2.2 mg per kg (0.5 to 1.0 mg per lb) intravenously, repeated at 24-hour intervals as necessary.

• Veterinary Supervision: Dosage schedules, route selection, and treatment duration must be determined and monitored exclusively by a licensed veterinarian.

Important Safety Information

• Contraindications: Do not administer to animals with known hypersensitivity to flunixin meglumine, pre-existing gastrointestinal ulceration, renal disease, hepatic dysfunction, or bleeding disorders. Do not use concurrently with other NSAIDs or systemic corticosteroids.

• Side Effects and Precautions: Prolonged use or overdosage carries a risk of gastric or right dorsal colon ulceration, renal papillary necrosis, and hypoproteinemia. Accidental perivascular injection in horses can cause localized tissue irritation or swelling; intravenous administration must be performed with care.

• Withdrawal Periods: Observe mandatory meat and milk withdrawal intervals established by regulatory authorities if treating food-producing livestock or equines intended for human consumption (typically 4 days for meat and 36 hours for milk in cattle, depending on regional regulations).

• Professional Guidance: Due to its active systemic impact, use must be managed under direct veterinary clinical oversight.

Storage and Handling

• Store at controlled room temperature between 15°C and 30°C (59°F to 86°F), protected from excessive heat and direct sunlight. Do not freeze.

• Maintain strict aseptic technique when puncturing the vial stopper to prevent microbial contamination.

• Keep securely out of reach of children, unauthorized individuals, and animals at all times.

Frequently Asked Questions

What is Flunixin Meglumine Injectable Solution used for?

It is a professional veterinary NSAID injection utilized to rapidly relieve acute visceral pain (such as equine colic), musculoskeletal inflammation, fever, and endotoxic shock in horses and cattle.

What is the active ingredient?

It contains flunixin meglumine at 50 mg/mL, a potent non-selective cyclooxygenase inhibitor that blocks inflammatory prostaglandin production.

How is the injection administered?

It is administered via intravenous or intramuscular injection following precise weight-based guidelines under veterinary supervision.

Order Rx Flunixin Meglumine Injection Online

Rx Flunixin Meglumine Injectable Solution (50 mg/mL) is available for order through our platform subject to veterinary prescription verification and regulatory compliance. For assistance regarding prescription submission, stock availability, or secure shipping protocols, please contact our customer support team.